Home › Agent Hub › Agent Tools › Part D coverage by drug › Triazolam
Agent Tools
Triazolam is a generic drug. What agents check before quoting it: how many 2027 Part D plans cover it, on which tier, with what restrictions and copays, by plan type, carrier and state.
In 2027, 873 of 5,492 Medicare Part D and Medicare Advantage drug plans (15.9%) list Triazolam on their formulary, across 28 of 286 formularies. The most common placement is tier 4 (685 plans, 78.5% of those covering it). 636 of the covering plans require prior authorization (72.9%), 0 step therapy and 738 a quantity limit.
165 covering plans charge a flat copay for a 30-day supply at a preferred retail pharmacy after the deductible — median $5, 69 of them $0; 708 charge coinsurance instead — median 28% of the drug's cost. Once a member's out-of-pocket drug spending reaches $2,400 in 2027, covered drugs cost $0 for the rest of the year.
2026: 970 of 5,496 plans covered it (17.6%); 2027: 873 of 5,492 (15.9%).
Of 4,367 plans offered in both years, 12 added it to the formulary and 40 dropped it.
Among plans covering it both years, 0 moved it to a higher tier and 1 to a lower one; 0 added prior authorization and 0 removed it.
| Tier | Plans |
|---|---|
| Tier 1 | 10 |
| Tier 2 | 154 |
| Tier 3 | 24 |
| Tier 4 | 685 |
| Plan type | Plans covering | Share | Prior auth |
|---|---|---|---|
| Stand-alone Part D (PDP) | 0 of 323 | 0% | — |
| Medicare Advantage with drugs (MA-PD) | 605 of 3,200 | 18.9% | 73.2% |
| Special needs plans (SNP) | 268 of 1,969 | 13.6% | 72% |
| Carrier | Plans covering | Usual tier | Prior auth |
|---|---|---|---|
| Humana | 0 of 846 | No tier listed | 0 |
| UnitedHealthcare | 0 of 830 | No tier listed | 0 |
| Devoted Health | 0 of 728 | No tier listed | 0 |
| Aetna Medicare | 611 of 631 | Tier 4 | 611 |
| Wellcare | 0 of 268 | No tier listed | 0 |
| HealthSpring | 0 of 226 | No tier listed | 0 |
| Kaiser Permanente | 112 of 112 | Tier 2 | 0 |
| SCAN Health Plan | 0 of 83 | No tier listed | 0 |
| Highmark Blue Cross Blue Shield or Highmark Blue Shield | 12 of 80 | Tier 4 | 12 |
| Alignment Health Plan | 0 of 77 | No tier listed | 0 |
| Anthem Blue Cross and Blue Shield | 0 of 74 | No tier listed | 0 |
| Wellpoint | 0 of 63 | No tier listed | 0 |
| Priority Health Medicare | 0 of 40 | No tier listed | 0 |
| CarePlus Health Plans, Inc. | 0 of 37 | No tier listed | 0 |
| Zing Health | 0 of 36 | No tier listed | 0 |
| Capital Blue Cross | 0 of 35 | No tier listed | 0 |
| Prominence Health Plan | 0 of 29 | No tier listed | 0 |
| Medica | 0 of 27 | No tier listed | 0 |
| Anthem HealthKeepers | 0 of 26 | No tier listed | 0 |
| Blue Cross Blue Shield of Michigan | 0 of 26 | No tier listed | 0 |
| State | Plans covering | Share |
|---|---|---|
| Alabama | 10 of 114 | 8.8% |
| Alaska | 0 of 9 | 0% |
| American Samoa | 0 of 1 | 0% |
| Arizona | 13 of 147 | 8.8% |
| Arkansas | 17 of 85 | 20% |
| California | 95 of 397 | 23.9% |
| Colorado | 26 of 106 | 24.5% |
| Connecticut | 11 of 54 | 20.4% |
| Delaware | 5 of 43 | 11.6% |
| District of Columbia | 5 of 12 | 41.7% |
| Florida | 86 of 545 | 15.8% |
| Georgia | 28 of 149 | 18.8% |
| Guam | 0 of 1 | 0% |
| Hawaii | 6 of 50 | 12% |
| Idaho | 0 of 45 | 0% |
| Illinois | 20 of 132 | 15.2% |
| Indiana | 13 of 138 | 9.4% |
| Iowa | 10 of 64 | 15.6% |
| Kansas | 22 of 84 | 26.2% |
| Kentucky | 13 of 121 | 10.7% |
| Louisiana | 12 of 125 | 9.6% |
| Maine | 5 of 52 | 9.6% |
| Maryland | 10 of 49 | 20.4% |
| Massachusetts | 13 of 89 | 14.6% |
| Michigan | 12 of 182 | 6.6% |
| Minnesota | 7 of 63 | 11.1% |
| Mississippi | 16 of 104 | 15.4% |
| Missouri | 39 of 170 | 22.9% |
| Montana | 0 of 27 | 0% |
| Nebraska | 7 of 51 | 13.7% |
| Nevada | 19 of 100 | 19% |
| New Hampshire | 0 of 25 | 0% |
| New Jersey | 14 of 73 | 19.2% |
| New Mexico | 3 of 68 | 4.4% |
| New York | 43 of 215 | 20% |
| North Carolina | 20 of 176 | 11.4% |
| North Dakota | 3 of 26 | 11.5% |
| Northern Mariana Islands | 0 of 1 | 0% |
| Ohio | 29 of 171 | 17% |
| Oklahoma | 7 of 81 | 8.6% |
| Oregon | 6 of 92 | 6.5% |
| Pennsylvania | 80 of 323 | 24.8% |
| Puerto Rico | 0 of 64 | 0% |
| Rhode Island | 3 of 29 | 10.3% |
| South Carolina | 14 of 89 | 15.7% |
| South Dakota | 7 of 30 | 23.3% |
| Tennessee | 9 of 156 | 5.8% |
| Texas | 51 of 407 | 12.5% |
| U.S. Virgin Islands | 0 of 1 | 0% |
| Utah | 9 of 53 | 17% |
| Vermont | 0 of 14 | 0% |
| Virginia | 20 of 144 | 13.9% |
| Washington | 22 of 114 | 19.3% |
| West Virginia | 16 of 69 | 23.2% |
| Wisconsin | 15 of 96 | 15.6% |
| Wyoming | 0 of 13 | 0% |
Medicare Part D paid for 108,682 30-day fills of Triazolam in 2024 for about 43,388 enrollees, at an average total cost of $32.18 per 30-day fill (CMS Part D Prescribers by Geography and Drug, national).
Price Triazolam and the rest of a client's list on every plan in their county.
Estimate Triazolam costs by plan
Free tools for licensed insurance agents. Data from CMS public files; verify with plan documents before advising a client.
Counts are over every Medicare Advantage drug plan and stand-alone Part D plan in the CMS monthly formulary files, excluding employer plans. A plan counts as covering a drug when any strength or form of it is on the plan’s formulary; the tier, prior authorization, step therapy and quantity limit shown are the most favorable version on that formulary. Copays are for a 30-day supply at a preferred retail pharmacy after the deductible. This is a reference for licensed agents, not a plan recommendation; verify with the plan’s formulary before advising a client. Source: CMS Part D formulary files (release 10/08/2026). CMS formulary data.